Tyme Technologies Inc. (TYME) Fundamentals

Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.
SHARE INFORMATION
Market Cap$ 53,504,682
Shares Outstanding172,206,894
Float128,778,602
Percent Float74.78%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.13
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions133
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months259,988
Institutional Holdings Percent10.0%
Institutional Sold Previous 3 Months7,660,448
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months528,000
Insider Holdings Percent25.0
Insider Sold Previous 3 Months1,112,500
Insider Shares Owned43,067,108
TRADING INFO
52 Week High$ 1.05
52 Week Low$ 0.22
52 Week High Change$ -68.93
21 Day Moving Average$ 0.2911
21 Day Extended Moving Average$ 0.30207
50 Day Moving Average$ 0.3013
50 Day Extended Moving Average$ 0.29821
200 Day Moving Average$ 0.345091
200 Day Extended Moving Average$ 0.424138
10 Day Average Volume-
20 Day Average Volume661,491
30 Day Average Volume522,923
50 Day Average Volume638,065
Alpha-0.029829
Beta0.8040
Standard Deviation0.223486
R20.035184
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.03
21 Day Percent Change10.69%
30 Day Price Change$ 0.0258
30 Day Percent Change9.06%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ -0.0414
180 Day Percent Change-11.76%
200 Day Price Change$ -0.0213
200 Day Percent Change-6.42%
Year to Date Price Change$ -0.2924
Year to Date Percent Change-48.48%

Tyme Technologies Inc. (TYME) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage-396.50
Current Ratio14.10
Leverage Ratio1.10
Quick Ratio13.70
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-2.20
Enterprise Value$ -23,574,012
Price to Sales0.00
Price to Free Cash-2.60
PE High Last 5 Years-6.20
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years-10.80
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-28.25
Return on Equity-30.35
Return on Capital-28.28

Tyme Technologies Inc. (TYME) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorGrant Thornton LLP
CEORichard Cunningham
Emplyoees13
Last AuditUQ
CIK0001537917
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1 Pluckemin Way
Suite 103
Bedminster, NJ 7921
Websitehttps://www.tymeinc.com
Facsimile-
Telephone+1 212 461-2315
Emailinvestorrelations@tymeinc.com


Your Recent History
NASDAQ
TYME
Tyme Techn..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.